Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Non-cash Items (2016 - 2018)

Tandem Diabetes Care's Non-cash Items history spans 6 years, with the latest figure at $117.0 million for Q4 2018.

  • For Q4 2018, Non-cash Items rose 19312.39% year-over-year to $117.0 million; the TTM value through Dec 2018 reached $117.0 million, up 19312.39%, while the annual FY2018 figure was $117.0 million, 19312.39% up from the prior year.
  • Non-cash Items reached $117.0 million in Q4 2018 per TNDM's latest filing, up from $602646.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $117.0 million in Q4 2018 to a low of $602646.0 in Q4 2017.
  • Average Non-cash Items over 5 years is $32.4 million, with a median of $19.2 million recorded in 2015.
  • Peak YoY movement for Non-cash Items: crashed 91.68% in 2016, then surged 19312.39% in 2018.
  • A 5-year view of Non-cash Items shows it stood at $23.5 million in 2014, then decreased by 18.59% to $19.2 million in 2015, then plummeted by 91.68% to $1.6 million in 2016, then crashed by 62.17% to $602646.0 in 2017, then soared by 19312.39% to $117.0 million in 2018.
  • Per Business Quant, the three most recent readings for TNDM's Non-cash Items are $117.0 million (Q4 2018), $602646.0 (Q4 2017), and $1.6 million (Q4 2016).